Table 2 Comparing the proportion of patients initiated on ART within 14 days of eligibility between START-ART intervention and the sustainability period
Number of patients during the intervention (n/N) | Number of patients after the intervention (n/N) | Risk ratio (95% CI) | p value | |
|---|---|---|---|---|
Sex* | ||||
Male | 129/160 (80.60) | 143/161 (88.82) | 1.102 (1.003–1.210) | 0.043 |
Female | 210/278 (75.54) | 231/263 (87.83) | 1.163 (1.073–1.260) | 0.0001 |
Location | ||||
Peri-urban | 149/192 (77.60) | 177/191 (92.67) | 1.194 (1.096–1.301) | 0.0001 |
Rural | 190/246 (77.24) | 198/234 (84.62) | 1.096 (1.004–1.195) | 0.040 |
Age at eligibility (years) | ||||
≤ 35 | 251/317 (79.18) | 269/298 (90.27) | 1.14 (1.065–1.220) | 0.0001 |
> 35 | 88/121 (72.73) | 106/127 (83.46) | 1.15 (1.004–1.312) | 0.044 |
ART eligibility CD4 (cells/ml)* | ||||
≤ 50 cells/ml | 18/20 (90) | 9/11 (81.82) | 0.909 (0.664–1.245) | 0.553 |
> 50 cells/ml | 321/418 (76.80) | 295/335 (88.06) | 1.147 (1.074–1.225) | 0.001 |
Eligibility WHO stage* | ||||
Stages 1 and 2 | 281/358 (78.49) | 53/396 (89.14) | 1.132 (1.062–1.206) | 0.0001 |
Stages 3 and 4 | 29/33 (87.88) | 15/18 (83.88) | 0.948 (0.744–1.208) | 1.208 |
Tuberculosis at ART eligibility | ||||
No tuberculosis | 337/436 (77.29) | 363/411 (96.35) | 1.143 (1.074–1.216) | 0.0001 |
Tuberculosis | 2/2 (100.0) | 12/14 (85.71) | 0.819 (0.661–1.014) | 0.0670 |
Health center level | ||||
HC3 | 223/281 (79.36) | 266/308 (86.36) | 1.088 (1.010–1.172) | 0.0260 |
HC4 | 116/157 (73.89) | 109/117 (93.16) | 1.261 (1.135–1.401) | 0.0001 |